Buch

Biography

Fredrik Buch, Ph.D., served as the Head of Clinical Research & Biostatistics at Pfizer Health AB. Dr. Buch is a Partner at Ekomarine AB and Brilleon Capital AG. He is employed at Ampezzo Capital PCC Ltd. He joined Brilleon in 2002. Since 2004, Dr. Buch has been acting as financial advisor to start-up companies, raising capital and serving on various boards in Sweden and abroad. He has significant experience from both clinical work and drug development in the pharma segment as well as profound experience in company start-ups, fund investing and financing. Prior to that, Dr. Buch served as a Partner of HealthCap from 2000 to 2003 and HealthCap Fund III. He was Partner of ABFBRH Investment AG. He was employee at Bristol-Myers Squibb AB. Dr. Buch served as the Head of SEB Healthcare Funds from 1997 to 2000. He joined HealthCap in 2000. Dr. Buch served at SEB Investment Management AB and supervised the SEB Healthcare Fund. He was the Head of Clinical Research and Biostatistics in urology, gynecology and autoimmune diseases at Pharmacia-Upjohn. Dr. Buch served as a Medical Director at Svenska Hoechst AB and Squibb Scandinavia. Dr. Buch has been Chairman of Huvudsta Vårdcentral AB since 2010 and Sequiente Capital AB (Investment company since 2007. He serves as the Chairman of Siguiente Capital (publ) AB. He has been the Chairman of the Board at Follicum AB (publ) since 2014 and serves as its Director. Dr. Buch joined PILA PHARMA in 2016. Dr. Buch has been a Director of the Boards positions in Sweden of Lantmännen AS-Faktor AB since 2005, The Medicines Company AB since 2009, The Medicines Company Oy since 2009), Lobsor Pharmaceuticals AB since 2014 and Bonvisi AB since 2016. He has been a Director of PILA PHARMA AB since 2016. Dr. Buch serves as a Director of Inion Oy, Brilleon Capital AG, Ekomarine AB and Selectica Pharmaceuticals AB. He served as a Director of Alpha Helix Molecular Diagnostics AB. He served as a Director of ABFBRH Investment AG. He served as a Director of Carmeda AB since 2001. He has an extensive investor experience from working as fund commissioner at the Swedish Bank SEB. He has held several clinical research positions in Pharma/Biotech from 1987 to 1996 including Bristol Myers Squibb, Hoechst, Pharmacia and Pharmacia & Upjohn and is the author of more than 20 scientific publications. Dr. Buch is the author of ten scientific articles in the area of Bone Biology. He served as Lecturer at the Institute of Anatomy, University of Gothenburg. Dr. Buch completed his medical training from the University of Gothenburg in 1981. Dr. Buch is an orthopaedic surgeon and scientist by training. He holds an M.D in medicine (1975) and a PhD from the University of Gothenburg (1985).

Research Interest

Orthopaedics